Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07140367

"Transarterial Microembolization (TAME) in Inflammatory Knee Pathology"

Sponsor: Istituto Ortopedico Rizzoli

View on ClinicalTrials.gov

Summary

Patients with knee OA and chronic pain refractory to at least 3 months of conventional conservative therapy will be included in the study, which will evaluate the clinical results obtained after treatment with selective arterial embolization (selection and enrollment, treatment with selective arterial embolization, follow-up checks). Forty-three patients will be included in the study and will undergo the transarterial microembolization procedure after signing the informed consent form for participation in the study and the collection of anamnestic data. Subsequently, patients will be followed up with clinical evaluation at 1, 3, 6, 12, and 24 months of follow-up or until possible dropout for other treatment.

Official title: "Transarterial Microembolization (TAME) in Inflammatory Knee Pathology: Prospective Observational Study."

Key Details

Gender

All

Age Range

40 Years - Any

Study Type

OBSERVATIONAL

Enrollment

43

Start Date

2025-09-01

Completion Date

2031-09-01

Last Updated

2026-04-07

Healthy Volunteers

No

Interventions

PROCEDURE

Transarterial Microembolization

Identification of the hypervascularization of the knee. Selective and super-selective catheterization of pathological genicular arterial branches, through the use of micro-catheters. - Injection of embolizing material (Nexsphere-F - Kardia) - Control of technical success: the embolization will be followed by diagnostic arteriography that will evaluate the success of the procedure (occlusion of more than 90 percent of the pathologic vasculature).

Locations (1)

IRCCS Istituto Ortopedico Rizzoli

Bologna, Bologna, Italy